Skip to main content
. 2020 Jan 20;2020(1):CD011628. doi: 10.1002/14651858.CD011628.pub2

10.2. Analysis.

10.2

Comparison 10 Guselkumab 200 mg vs placebo, Outcome 2 Proportion of participants with adverse effects serious or severe enough to have caused withdrawal of participants from the study.